229 related articles for article (PubMed ID: 12747793)
1. C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.
Kim MG; Bodor ET; Wang C; Harden TK; Kohn H
J Med Chem; 2003 May; 46(11):2216-26. PubMed ID: 12747793
[TBL] [Abstract][Full Text] [Related]
2. C(8)-substituted 1-azabicyclo[3.3.1]non-3-enes: a novel scaffold for muscarinic receptor ligands.
Kim MG; Bodor ET; Harden TK; Kohn H
Bioorg Med Chem; 2004 May; 12(9):2357-67. PubMed ID: 15080933
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of (1-azabicyclo[3.3.0]octanyl)methyl-substituted aromatic heterocycles and their muscarinic activity.
Suzuki T; Uesaka H; Hamajima H; Ikami T
Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):876-9. PubMed ID: 10399839
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.
Lainé DI; Wan Z; Yan H; Zhu C; Xie H; Fu W; Busch-Petersen J; Neipp C; Davis R; Widdowson KL; Blaney FE; Foley J; Bacon AM; Webb EF; Luttmann MA; Burman M; Sarau HM; Salmon M; Palovich MR; Belmonte K
J Med Chem; 2009 Aug; 52(16):5241-52. PubMed ID: 19630384
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.
Triggle DJ; Kwon YW; Abraham P; Rahman MA; Carroll FI
Pharm Res; 1992 Nov; 9(11):1474-9. PubMed ID: 1475236
[TBL] [Abstract][Full Text] [Related]
6. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.
Hiebel AC; Lee YS; Bilsky E; Giuvelis D; Deschamps JR; Parrish DA; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Partilla JS; Rothman RB; Cheng K; Jacobson AE; Rice KC
J Med Chem; 2007 Aug; 50(16):3765-76. PubMed ID: 17625813
[TBL] [Abstract][Full Text] [Related]
7. 2-Azabicyclo[2.1.1]hexanes. 2. Substitutent effects on the bromine-mediated rearrangement of 2-azabicyclo[2.2.0]hex-5-enes.
Krow GR; Lee YB; Lester WS; Liu N; Yuan J; Duo J; Herzon SB; Nguyen Y; Zacharias D
J Org Chem; 2001 Mar; 66(5):1805-10. PubMed ID: 11262131
[TBL] [Abstract][Full Text] [Related]
8. Ibogaine analogues. Synthesis and preliminary pharmacological evaluation of 7-heteroaryl-2-azabicyclo[2.2.2]oct-7-enes.
Passarella D; Favia R; Giardini A; Lesma G; Martinelli M; Silvani A; Danieli B; Efange SM; Mash DC
Bioorg Med Chem; 2003 Mar; 11(6):1007-14. PubMed ID: 12614886
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues.
Carroll FI; Liang F; Navarro HA; Brieaddy LE; Abraham P; Damaj MI; Martin BR
J Med Chem; 2001 Jun; 44(13):2229-37. PubMed ID: 11405659
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structural determination of stereoisomers of muscarinic ligands of the (3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicycloalkane type.
Olesen PH; Sauerberg P; Petersen TG; Treppendahl S; Bentzen B; Deeter J; Ward JS; Mitch CH; Lehmann SV
Chirality; 1997; 9(8):739-49. PubMed ID: 9435099
[TBL] [Abstract][Full Text] [Related]
11. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.
Tecle H; Barrett SD; Lauffer DJ; Augelli-Szafran C; Brann MR; Callahan MJ; Caprathe BW; Davis RE; Doyle PD; Eubanks D; Lipiniski W; Mirzadegan T; Moos WH; Moreland DW; Nelson CB; Pavia MR; Raby C; Schwarz RD; Spencer CJ; Thomas AJ; Jaen JC
J Med Chem; 1998 Jul; 41(14):2524-36. PubMed ID: 9651157
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.
Lainé DI; Xie H; Buffet N; Foley JJ; Buckley P; Webb EF; Widdowson KL; Palovich MR; Belmonte KE
Bioorg Med Chem Lett; 2007 Nov; 17(22):6066-9. PubMed ID: 17911022
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of bicyclic sigma receptor ligands with cytotoxic activity.
Geiger C; Zelenka C; Weigl M; Fröhlich R; Wibbeling B; Lehmkuhl K; Schepmann D; Grünert R; Bednarski PJ; Wünsch B
J Med Chem; 2007 Nov; 50(24):6144-53. PubMed ID: 17967001
[TBL] [Abstract][Full Text] [Related]
15. Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.
Johansson G; Sundquist S; Nordvall G; Nilsson BM; Brisander M; Nilvebrant L; Hacksell U
J Med Chem; 1997 Nov; 40(23):3804-19. PubMed ID: 9371246
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 7-azabicyclo[2.2.1]heptane and 2-oxa-4-azabicyclo[3.3.1]non-3-ene derivatives by base-promoted heterocyclization of alkyl N-(cis(trans)-3,trans(cis)-4-dibromocyclohex-1-yl)carbamates and N-(cis(trans)-3,trans(cis)-4-dibromocyclohex-1-yl)-2,2,2-trifluoroacetamides.
Gómez-Sanchez E; Soriano E; Marco-Contelles J
J Org Chem; 2007 Nov; 72(23):8656-70. PubMed ID: 17927252
[TBL] [Abstract][Full Text] [Related]
17. Novel aryloxy-8-azabicyclo[3.2.1]oct-3-enes with 5-HT transporter and 5-HT1A affinity.
Gilbert AM; Coleman T; Kodah J; Mewshaw RE; Scerni R; Schechter LE; Smith DL; Andree TH
Bioorg Med Chem Lett; 2004 Nov; 14(21):5281-4. PubMed ID: 15454211
[TBL] [Abstract][Full Text] [Related]
18. 7-substituted 2-azabicyclo[2.2.1]heptanes as key intermediates for the synthesis of novel epibatidine analogues; synthesis of syn-and anti-isoepiboxidine.
Malpass JR; White R
J Org Chem; 2004 Aug; 69(16):5328-34. PubMed ID: 15287778
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
Wei ZL; Petukhov PA; Xiao Y; Tückmantel W; George C; Kellar KJ; Kozikowski AP
J Med Chem; 2003 Mar; 46(6):921-4. PubMed ID: 12620069
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
